Back

prof. dr. F.L.J. (Frank) Visseren

prof. dr. F.L.J. (Frank) Visseren

Full Professor

Show full profile

Research Output (568)

End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors:results from the UCC-SMART cohort study

Østergaard Helena Bleken, Westerink Jan, Verhaar Marianne C, Bots Michiel L, Asselbergs Folkert W, de Borst Gert J, Kappelle L Jaap, Visseren Frank L J, van der Leeuw Joep, 13 Mar 2021, In: Journal of Nephrology. 34 , p. 1511-1520 10 p.

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease:Results from the UCC-SMART prospective cohort study

De Vries Tamar Irene, Westerink Jan, Bots Michiel L., Asselbergs Folkert W., Smulders Yvo M., Visseren Frank L.J. 8 Mar 2021, In: BMJ Open. 11 , p. 1-10

Prediction models for recurrence and bleeding in patients with venous thromboembolism:A systematic review and critical appraisal

de Winter Maria A, van Es Nick, Büller Harry R, Visseren Frank L J, Nijkeuter Mathilde Mar 2021, In: Thrombosis Research. 199 , p. 85-96 12 p.

Predicting 10-year risk of recurrent cardiovascular events andcardiovascular interventions in patients with established cardiovascular disease:results from UCC-SMART and REACH

Klooster C. C.van t., Bhatt D. L., Steg P. G., Massaro J. M., Dorresteijn J. A.N., Westerink J., Ruigrok Y. M., de Borst G. J., Asselbergs F. W., van der Graaf Y., Visseren F. L.J., 15 Feb 2021, In: International Journal of Cardiology. 325 , p. 140-148 9 p.

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease

van 't Klooster Cilie C., van der Graaf Yolanda, Nathoe Hendrik M., Bots Michiel L., de Borst Gert J., Visseren Frank L.J., Leiner Tim, , van der Kaaij NP, Asselbergs Folkert 12 Feb 2021, In: The International Journal of Cardiovascular Imaging. 37 , p. 2051-2061 11 p.

Platelet aggregation inhibitor prescription for newly diagnosed peripheral arterial disease in the Netherlands:a cohort study

Brand Aarent Rt, Houben Eline, Bezemer Irene D, Visseren Frank L J, Bots Michiel L, Herings Ron Mc, de Borst Gert-Jan 20 Jan 2021, In: BMJ Open. 11 , p. 1-14

Applicability of Blood Pressure-Lowering Drug Trials to Real-World Patients With Cardiovascular Disease

Bonekamp Nadia E, Spiering Wilko, Nathoe Hendrik M, Kappelle L Jaap, de Borst Gert J, Visseren Frank L J, Westerink Jan, 2021, In: Hypertension (Dallas, Tex. : 1979). 77 , p. 357-366 10 p.

Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention

Gynnild Mari Nordbø, Hageman Steven H.J., Dorresteijn Jannick A.N., Spigset Olav, Lydersen Stian, Wethal Torgeir, Saltvedt Ingvild, Visseren Frank L.J., Ellekjær Hanne 2021, In: Clinical Epidemiology. 13 , p. 813-823 11 p.

Screening for abdominal aortic aneurysm in patients with clinically manifest vascular disease

de Boer Annemarijn R., Vaartjes Ilonca, van Dis Ineke, van Herwaarden Joost A., Nathoe Hendrik M., Ruigrok Ynte M., Bots Michiel L., Visseren Frank L.J., 7 Oct 2020, In: European Journal of Preventive Cardiology. 29 , p. 1170-1176 7 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not